Carpio CÓG, Sánchez NN, Turnbull IC, Serrano LJA

Language: Spanish
References: 13
Page: 145-148
PDF size: 86.19 Kb.

ABSTRACT

Background: The carotid body tumor is associated to latitudes with a high level over the sea, as the ones present in our country, being a highly vascularizated tumor with potential malignancy.
Objective: To search the current technological resources to reduce the morbidity and mortality of the carotid body tumor surgical treatment, and to expose our experience in our facility.
Results: The resources found for its treatment are the selective preoperative embolization, using a covered stent on the external carotid vessel, mandibular subluxation, use of a bipolar cautery, use of a carotid shunt, carotid vessel reconstruction. In our facility from May 2003 until January 2009, we had treated 38 patients with a carotid body tumor: Shamblin I, four patients (10.5%); Shamblin II, 30 patients (79%); Shamblin III, four patients (10.5%); with an average procedure timing of 108 ± 27.2 min (range 60-210 min), with a blood loose estimated in 486 ± 240 mL (range 200-1,600 mL), with morbidity because of lesion on carotid bifurcation 1(5.2%); internal carotid vessel lesion, 1(2.6%); lesion and ligature of internal jugular vessel, 1(2.6%); stroke, 1(2.6%); wound hematoma, 1(2.6%); hipoglosal nerve lesion, 2(5.2%); recurrent laryngeal nerve lesion, 1(2.6%). The procedure timing, bleeding and neurological lesion were directly related to the tumor diameter.
Conclusions: The diagnosis and early resection of the carotid body tumor, still remain, the key factors to diminish the morbidity and mortality associated with the resection of this nosological entity.

REFERENCES

1. Kakkos KS, Reddy JD, Shepard DA. Contemporary presentation and evolution of management of neck paragangliomas. J Vasc Surg 2009; 49: 1365-73.

2. Smith FR, Shetty CP, Reddy JD. Surgical treatment of carotid paragangliomas presenting unusual technical difficulties. J Vasc Surg 1988; 7: 631-7.

3. Hernández LE, Enríquez VME, Rodríguez JO. Correlación entre la presencia de tumores del cuerpo carotídeo e hipoxemia crónica. Estudio demostrado por gasometría arterial. Rev Mex Angiol 2009; 37: 82-7.

4. Enríquez VE, Velasco OC, Cruz CE. Saturación de oxígeno en pacientes con tumor de cuerpo carotídeo. Rev Mex Angiol 2003; 31: 68-71.

5. DuBois J, Kelly W, McMenamin P. Bilateral carotid body tumors managed with preoperative embolization: A case report and review. J Vasc Surg 1987; 5: 648-50.

6. Dossa C, Shepard DA, Wolford G. Distal internal carotid exposure: A simplified technique for temporary mandibular subluxation. J Vasc Surg 1990; 12: 319-25.

7. Scanlon MJ, Lustgarten JJ, Karr BS. Successful devascularization of carotid body tumors by covered stent placement in the external carotid artery. J Vasc Surg 2008; 48: 132-4.

8. Tripp FH, Fail SP, Beyer GM. New approach to preoperative vascular exclusion for carotid body tumor. J Vasc Surg 2003; 38: 389-91.

9. Roddy PS, et al. Presentation and evolution of management of 41 neck paragangliomas. J Vasc Surg 2009; 49: 1625.

10. Westerband A, Hunter CG, Cintora I. Current trends in the detection and management of carotid body tumors. J Vasc Surg 1998; 28: 84-93.

11. Flores EM, Serrano LJ, Rosas FMA y col. Tumor de cuerpo carotídeo, experiencia en el hospital Regional “Lic. Adolfo López Mateos” del ISSSTE. Rev Mex Angiol 2007; 35: 53-62.

12. Hallet WJ, Nora DJ, Hollier HL. Trends in neovascular complications of surgical management for carotid body and cervical paragangliomas: A fifty-year experience with 153 tumors. J Vasc Surg 1988; 7: 284-91.

13. Fillinger M. Carotid body tumor: three-dimensional imaging. J Vasc Surg 2003; 37: 913.